Mersana Therapeutics to Report Updated Data from the XMT-1536 Phase 1 Dose Escalation Study

    NEXT STORY
    Chembio Diagnostics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
    PREV STORY
    Global Lamellar Ichthyosis (LI) Market Insights, 2017-2030: Epidemiology, Trends, Drivers, Unmet Needs, Emerging Drugs
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Medical Design & Manufacturing (MD&M) Minneapolis Announces its 2019 Programming for its 25th Year Celebrating Life-Saving Innovations

    author_avatar
    NASDAQ Market News

    Trillium Therapeutics Reports TTI-622 Preclinical Data at the 2018 AACR Annual Meeting

    author_avatar
    NASDAQ Market News

    VBL Therapeutics to Report Fourth Quarter & Fiscal Year 2015 Financial Results on March 29

    TEL AVIV, Israel, March 07, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

    author_avatar
    NASDAQ Market News